An increasing number of studies, particularly on endocrine disrupting chemicals have recently supported the idea of adverse effects at ‘low doses’. Even though the issues are still debated, the cumulating findings point the way towards the need for a change in how toxicological data is interpreted and risk assessment procedures are performed. In mid June, an international group of 100 experts were brought together for the European Food Safety Authority’s 17th Scientific Colloquium to discuss the scientific evidence and implications of the “low-dose hypothesis” for the future of public health and the environment. The outcome of the colloquium will be summarised in a report to be published in the autumn.
Written on 10 July 2012.